MetaCap

Chemours (CC) vs Innospec (IOSP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Innospec (IOSP) has outperformed Chemours (CC) over the past year, gaining 4.8% versus a loss of 1.5%. Over five years, IOSP leads with a -9.2% price change compared with -64.7% for CC. Innospec is the larger company by market cap ($1.86 billion vs $1.64 billion), about 1.1 times the size, while Chemours is growing revenue faster (+0.4% vs -3.7%).

On valuation, Chemours trades at a lower forward P/E (6.3x vs 12.7x for Innospec). Chemours offers the higher dividend yield (3.22% vs 2.37%). Innospec converts more of its revenue into profit, with a net margin of 6.6% versus -6.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CC-1.54%IOSP+4.76%
+161%+72%-17%
Nov 21, 20251 yearNov 20, 2026
CC-65.73%IOSP-13.48%
+56%-9%-74%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CC versus IOSP key metrics
MetricCCIOSP
Share price$10.88$75.56
Market cap$1.64B$1.86B
1-day change-7.80%-1.97%
YTD return-7.72%-1.28%
1-year return-1.54%+4.76%
5-year return-64.73%-9.17%
P/E ratio (TTM)—13.35
Forward P/E6.3112.66
EPS (TTM)$-1.12$5.66
Dividend yield3.22%2.37%
Annual dividend$0.35$1.79
Revenue (latest FY)$5.81B$1.78B
Revenue growth (YoY)+0.45%-3.65%
Net income (latest FY)$-386.00M$116.60M
Gross margin15.53%27.69%
Operating margin—7.28%
Net margin-6.65%6.56%
52-week high$28.67$102.00
52-week low$10.83$65.51
Distance from 52-week high-62.05%-25.92%
Analyst consensusholdstrong_buy
Avg. price target upside+47.06%+31.46%
Average volume2.14M235.15K
Shares outstanding150.52M24.63M
Employees5,7002,450
SectorIndustrialsIndustrials
IndustryMajor ChemicalsMajor Chemicals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Innospec is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -6.6 cents for Chemours.

About Chemours

CC stock →

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.

Industrials · Major Chemicals · 5,700 employees

About Innospec

IOSP stock →

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.

Industrials · Major Chemicals · 2,450 employees

CC vs IOSP FAQ

Which is bigger, Chemours or Innospec?

Innospec (IOSP) is larger, with a market capitalization of $1.86B compared with $1.64B for Chemours (CC).

Which stock has performed better over the past year, CC or IOSP?

IOSP returned +4.76% over the past 12 months, compared with -1.54% for CC (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Chemours or Innospec?

Chemours has the higher yield at 3.22%, compared with 2.37% for Innospec.

Are Chemours and Innospec in the same industry?

Yes. Both are classified in the Major Chemicals industry within the Industrials sector.

More comparisons